» Articles » PMID: 6893656

Complement-induced Vascular Leukostasis. Its Role in Tissue Injury

Overview
Specialty Pathology
Date 1980 Dec 1
PMID 6893656
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The plasma complement system evolved as a beneficial antimicrobial mechanism. However, this system can be activated chaotically in such situations as extracorporeal perfusion, trauma, sepsis, or acute pancreatitis. When so activated, the complement component C5a may aggregate granulocytes and cause leukoembolization; it is suggested that such leukoembolization is an important, previously unsuspected mechanism of tissue damage. In addition, toxic oxygen species, such as superoxide, that are produced by granulocytes that have been triggered by C5a can damage the endothelium, an event that may, if it occurs in the lungs, contribute to the development of the adult respiratory distress syndrome (ARDS). Hence the previously empiric use of high doses of corticosteroids in treating shock states, particularly in cases of the ARDS, may have a physiologic basis since very high concentrations of such drugs have been shown to inhibit both superoxide production and granulocyte aggregation.

Citing Articles

Requirement and role of C5a in acute lung inflammatory injury in rats.

Mulligan M, Schmid E, Beck-Schimmer B, Till G, Friedl H, Brauer R J Clin Invest. 1996; 98(2):503-12.

PMID: 8755663 PMC: 507456. DOI: 10.1172/JCI118818.


Inflammatory mediators released by complement-derived peptides.

Bult H, Herman A Agents Actions. 1983; 13(5-6):405-14.

PMID: 6416038 DOI: 10.1007/BF02176403.


Steroids inhibit activation of the alternative-amplification pathway of complement.

Packard B, Weiler J Infect Immun. 1983; 40(3):1011-4.

PMID: 6343236 PMC: 348151. DOI: 10.1128/iai.40.3.1011-1014.1983.


Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Sundsmo J, Fair D Springer Semin Immunopathol. 1983; 6(2-3):231-58.

PMID: 6227099 DOI: 10.1007/BF00205875.


Formation of prostanoids during intravascular complement activation in the rabbit.

Bult H, Herman A, Laekeman G, Rampart M Br J Pharmacol. 1985; 84(2):329-36.

PMID: 3884074 PMC: 1987301. DOI: 10.1111/j.1476-5381.1985.tb12917.x.